NK

NantKwest
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.246
-0.014
-1.09%
Opening 15:55 10/16 EDT
OPEN
1.250
PREV CLOSE
1.260
HIGH
1.260
LOW
1.210
VOLUME
71.92K
TURNOVER
--
52 WEEK HIGH
4.100
52 WEEK LOW
0.9300
MARKET CAP
122.52M
P/E (TTM)
-1.3745
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of NK and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Underperform

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

NK News

  • Does NantKwest, Inc.'s (NASDAQ:NK) CEO Pay Reflect Performance?
  • Simply Wall St..10/02 15:40
  • Who Has Been Selling NantKwest, Inc. (NASDAQ:NK) Shares?
  • Simply Wall St..08/27 15:21
  • NantKwest: Continues To Sell Off Despite The Clinical Progress
  • Seeking Alpha - Article.07/12 07:08
  • Did Changing Sentiment Drive NantKwest's (NASDAQ:NK) Share Price Down A Painful 82%?
  • Simply Wall St..07/11 11:58

More

Industry

Biotechnology & Medical Research
+0.16%
Pharmaceuticals & Medical Research
+0.05%

Hot Stocks

Name
Price
%Change

About NK

NantKwest, Inc. is a clinical-stage immunotherapy company. The Company is focused on harnessing the power of the innate immune system by using the natural killer cell to treat cancer, infectious diseases and inflammatory diseases. Its immuno-oncology NK platform has multiple modes to induce cell death against the tumor or infected cell by direct killing by binding to stress ligands expressed by the diseased cell with the release of toxic granules directly into the tumor cell; antibody mediated killing by binding to antibodies administered in combination and enhancing the cancer killing effect of the administered antibody, enabling targeted cell killing through antibody dependent cellular cytotoxicity (ADCC), and target activated killing by binding to known or newly discovered tumor-specific antigens expressed on the surface of tumor cells and inducing cell death by the release of toxic granules directly into the tumor cell and by the release of cytokines and chemokines.
More

Webull offers Nantkwest Inc (NK) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.